U-Chart Analysis:NANO MRNA Co., Ltd.:4571

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index NANO MRNA Co., Ltd. Go to web site 4571 Medicals 東証グロース March 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

NANO MRNA Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Balance Sheet 2025年3月期 NANO MRNA Co., Ltd. Balance Sheet 2024年3月期 NANO MRNA Co., Ltd. Balance Sheet 2023年3月期 NANO MRNA Co., Ltd. Balance Sheet 2022年3月期 NANO MRNA Co., Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 1,707 2,078 2,812 3,545 3,892
Other Current AssetsHelp 1,914 2,384 1,857 2,759 3,010
Tangible Fixed AssetsHelp 0 0 0 7 4
Intangible Fixed AssetHelp 0 0 0 0 13
Investments and OthersHelp 375 609 1,115 825 901
Total AssetsHelp 3,997 5,071 5,784 7,136 7,821
Total Current LiabilitiesHelp 1,257 541 422 419 321
Total Long-term LiabilitiesHelp - 1,109 1,109 1,150 0
Shareholder's EquityHelp 2,740 3,421 4,253 5,567 7,500
Total LiabilitiesHelp 3,997 5,071 5,784 7,136 7,821

NANO MRNA Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Profit and Loss Account 2025年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2024年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2023年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2022年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 109 136 202 264 313
Total Sales 109 136 202 264 313
Cost of SalesHelp 30 25 43 41 38
Other Costs and RevenueHelp 914 891 1,471 2,104 3,111
Total CostsHelp 944 916 1,513 2,146 3,149
Net RevenueHelp 78 111 160 223 275
Earnings Before TaxHelp -833 -778 -1,308 -1,879 -2,832
Net IncomeHelp -835 -780 -1,311 -1,882 -2,836
Net Income -835 -780 -1,311 -1,882 -2,836

NANO MRNA Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Cash Flow Statement 2025年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2024年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2023年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2022年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help -402 -585 -1,055 -1,753 -1,200
Investing Cash Flow(ICF)Help 588 793 1,208 -244 -872
Financing Cash FlowHelp - -569 4 1,146 -11
Exchange Difference of Cash and Cash EquivalentsHelp - 627 56 57 5
Net Increase and Decrease in Cash and Cash Equivalentsn -378 266 213 -795 -2,079

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

NANO MRNA Co., Ltd.

Company where related level is highHelp

LTT Bio-Pharma Co.,Ltd.
Takeda Pharmaceutical Company Limited
Oncolys BioPharma Inc.
Carna Biosciences,Inc.
OncoTherapy Science,Inc.
StemRIM Inc.
Cyfuse Biomedical K.K.
TAIKO PHARMACEUTICAL CO.,LTD.
MIZUHO MEDY CO.,LTD.
Sanko Junyaku Co.,Ltd.